Ampiroxicam

Drug Profile

Ampiroxicam

Alternative Names: CP 65703; Flucam; Nacyl

Latest Information Update: 14 Jul 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Developer Toyama Chemical
  • Class Antirheumatics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Rheumatic disorders

Most Recent Events

  • 01 Jul 2008 Toyama Chemical has been acquired by FUJIFILM Holdings Corporation
  • 23 Jun 2000 Pfizer has merged with Warner-Lambert
  • 07 Apr 2000 A study in rats has been added to the drug interactions section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top